All Stories

  1. Exploring Melanoma Awareness in the Australian Adult Population: A Cross‐Sectional Survey
  2. 3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk
  3. The Impact of Multidisciplinary Research on Progress in Skin Cancer Prevention
  4. Automating skin colour assessment using 3D total‐body photography: A proof‐of‐concept study
  5. An Overview of Data Analysis Approaches and Biases in Unveiling the Impact of COVID-19 on Melanoma Diagnosis
  6. A longitudinal dataset of tile and corresponding dermoscopic images with metadata for identifying skin cancers
  7. Practice Guidelines for Teledermatology in Australia: 2025 Update
  8. Three-Dimensional Total Body Photography Enables Automated Obesity-Related Comorbidity Screening in Dermatology
  9. Understanding Contemporary Endometrial Cancer Survivorship Issues: Umbrella Review and Healthcare Professional Survey
  10. Privacy in Imaging for Dermatology Research
  11. What Are Patients’ Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review
  12. Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia
  13. Unpredictable interdependence of invasive and in situ melanoma
  14. Attitudes Towards the Use of Artificial Intelligence in Dermatology: A Survey of Australian Dermatologists
  15. The deep imaging phenotype for melanoma risk stratification
  16. Estimation of Body Mass Index from 3-Dimensional Total Body Photography
  17. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study
  18. Combining Automated Lesion Risk and Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study
  19. Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology
  20. The impact of surgical complications on obstetricians’ and gynecologists’ well-being and coping mechanisms as second victims
  21. Sun safe practice in the sport sector: industry forum report September 2025
  22. Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma
  23. Automated Detection of Pigmented Iris Freckles Using a Deep Neural Network for Cutaneous Melanoma Risk
  24. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses
  25. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study
  26. Targeted Screening for Cancer: Learnings and Applicability to Melanoma: A Scoping Review
  27. Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study
  28. Protocol for the process evaluation of the GOAL trial: investigating how comprehensive geriatric assessment (CGA) improves patient-centred goal attainment in older adults with chronic kidney disease in the outpatient setting
  29. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study (Preprint)
  30. A Narrative Review: Opportunities and Challenges in Artificial Intelligence Skin Image Analyses Using Total Body Photography
  31. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses (Preprint)
  32. Working together to improve type 2 diabetes care: a Participatory Design project to address identified needs of people with diabetes and their healthcare professionals
  33. Balancing the risks and benefits of sun exposure: A revised position statement for Australian adults
  34. Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis
  35. Learnings from implementing a surgical training program
  36. Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol
  37. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study (Preprint)
  38. Melanoma screening workshop summary report
  39. Skin cancer awareness in the personal services industry
  40. Skin Cancer Prevention Queensland: Sunscreen Industry Forum Report
  41. Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial
  42. Position statement: balancing the harms and benefits of sun exposure
  43. Spatial Randomness in the Distribution of Acquired Melanocytic Nevi of the Back in a Population-Based Sample
  44. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial
  45. Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial
  46. Sun Exposure Summit position statement
  47. Consumer views of melanoma early detection using 3D total‐body photography: cross‐sectional survey
  48. Skin Cancer Prevention Queensland: towards a future of reduced skin cancer burden for Queenslanders
  49. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  50. The dynamic nature of naevi in adulthood: prospective population-based study using three-dimensional total-body photography
  51. Informing a position statement on the use of artificial intelligence in dermatology in Australia
  52. Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging
  53. Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?
  54. Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review
  55. Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles
  56. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  57. Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative Interview Study (Preprint)
  58. A qualitative analysis of the needs and wishes of people with type 2 diabetes and healthcare professionals for optimal diabetes care
  59. Experience from an outright ban of commercial sunbeds in the Australian context
  60. Digital Technology in Skin Cancer Prevention and Early Detection
  61. Digital Technology in Skin Cancer Prevention and Early Detection (Preprint)
  62. Reasons behind Low Cervical Screening Uptake among South Asian Immigrant Women: A Qualitative Exploration
  63. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study (Preprint)
  64. Factors influencing participants’ engagement with an interactive text-message intervention to improve sun protection behaviors: “SunText” randomized controlled trial
  65. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  66. The Additive Value of 3D Total Body Imaging for Sequential Monitoring of Skin Lesions: A Case Series
  67. Describing the Skin Surface Ecosystem Using 3D Total Body Photography
  68. Anatomic Distribution of Cherry Angiomas in the General Population
  69. Reproducible Naevus Counts Using 3D Total Body Photography and Convolutional Neural Networks
  70. The impact on health outcomes of implementing electronic health records to support the care of older people in residential aged care: A scoping review
  71. Review of educational tools for skin self‐examination: A qualitative analysis of laypeople’s preferences
  72. Weight and weight control behaviors during long‐term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long‐term follow‐up study
  73. High variability in anatomic patterns of cutaneous photodamage: a population‐based study
  74. Development of a Checklist Tool to Assess the Quality of Skin Lesion Images Acquired by Consumers Using Sequential Mobile Teledermoscopy
  75. Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study
  76. The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World
  77. Changes in cancer preventive behaviours, screening and diagnosis during COVID‐19
  78. Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?
  79. Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis
  80. Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.
  81. Fertility-sparing treatment in early endometrial cancer: current state and future strategies
  82. Virtual melanoma checks during a pandemic
  83. Practice guidelines for teledermatology in Australia
  84. Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit
  85. A review of literature supporting the development of practice guidelines for teledermatology in Australia
  86. The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia
  87. Consumer skin cancer screening preferences
  88. Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial
  89. Long‐term deaths from melanoma according to tumor thickness at diagnosis
  90. Tweets about sunburn
  91. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study
  92. Self‐reported naevus density may lead to misclassification of melanoma risk
  93. Using Mobile Health Technology and Social Media for the Prevention and Early Detection of Skin Cancer
  94. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  95. What Can Twitter Tell Us about Skin Cancer Communication and Prevention on Social Media?
  96. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review
  97. Unintended sunburn after applying sunscreen
  98. 3D Total Body Photography for early melanoma detection
  99. What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi‐disciplinary team
  100. Multidisciplinary cancer care in Australia
  101. UV detection stickers can assist people to reapply sunscreen
  102. Is there a role for digital technology in measuring the value of skin self‐examination?
  103. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review (Preprint)
  104. How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial
  105. Patient-Reported Experiences After Hysterectomy: A Cross-Sectional Study of the Views of Over 2300 Women
  106. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review
  107. Can clinical decision making be enhanced by artificial intelligence?
  108. Challenges and controversies in the conservative management of uterine and ovarian cancer
  109. How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?
  110. The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting
  111. Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer
  112. Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primary
  113. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial
  114. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review (Preprint)
  115. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma
  116. Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial
  117. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis
  118. Fighting Melanoma with Smartphones: A Snapshot of Where We are a Decade after App Stores Opened Their Doors
  119. Using Advances in Skin Imaging Technology and Genomics for the Early Detection and Prevention of Melanoma
  120. Why a randomized melanoma screening trial may be a good idea
  121. ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
  122. Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use
  123. Are psychological interventions effective on anxiety in cancer patients? A systematic review and meta-analyses
  124. All-cause death in young women with endometrial cancer who receive progesterone therapy
  125. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers
  126. Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancer
  127. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival
  128. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial (Preprint)
  129. Clinical trials, culture and language: More than meets the eye?
  130. Effect of solar ultraviolet radiation exposure on serum 25(OH)D concentration: a pilot randomised controlled trial
  131. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers (Preprint)
  132. Psychological distress among Indigenous Australian cancer survivors
  133. Time and treatments: It is what you make of it that counts
  134. Do hand-addressed envelopes improve community response rates for a longitudinal study?
  135. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors
  136. The validity and reliability of remote diabetic foot ulcer assessment using mobile phone images
  137. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years
  138. Nutrition interventions in patients with gynecological cancers requiring surgery
  139. Anxiety, depression and quality of life in people with pancreatic cancer and their carers
  140. Efficacy of smartphone applications in high-risk pigmented lesions
  141. The Living Well after Breast Cancer™ Pilot Trial: a weight loss intervention for women following treatment for breast cancer
  142. Greater Precision in Melanoma Prevention
  143. Factors associated with quality of care for patients with pancreatic cancer in Australia
  144. Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancer
  145. A Randomized Trial on the Effect of Exercise Mode on Breast Cancer–Related Lymphedema
  146. Consumer teledermoscopy for melanoma diagnosis
  147. Can skin cancer prevention be improved through mobile technology interventions? A systematic review
  148. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study
  149. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study
  150. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study
  151. Economics of teledermatology
  152. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study
  153. Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study
  154. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study
  155. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  156. Self-Reported Changes in Sun-Protection Behaviors at Different Latitudes in Australia
  157. Compression use during an exercise intervention and associated changes in breast cancer-related lymphedema
  158. Health-related quality of life among Indigenous Australians diagnosed with cancer
  159. Estimating Skin Cancer Risk: Evaluating Mobile Computer-Adaptive Testing
  160. Using a Delphi process to determine optimal care for patients with pancreatic cancer
  161. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  162. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients
  163. Mediation of improvements in sun protective and skin self-examination behaviours: results from the healthy text study
  164. Beyond survivorship? A discursive analysis of how people with pancreatic cancer negotiate identity transitions in their health
  165. A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services
  166. Review of the Evidence of Lymphedema Treatment Effect
  167. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
  168. Consumer preferences for teledermoscopy screening to detect melanoma early
  169. Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancer
  170. Redefining Dermatologists’ Role in Skin Cancer Early Detection and Follow-up Care
  171. Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: Results from the LACE trial
  172. Consumer Teledermoscopy
  173. Incidence, Risk Factors, and Estimates of a Woman’s Risk for Developing Secondary Lower Limb Lymphedema and Lymphedema-Specific Supportive Care Needs in Women Treated for Endometrial Cancer
  174. Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population
  175. User preferences for text message-delivered skin cancer prevention and early detection
  176. Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial
  177. Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?
  178. Systematic Review of Interventions to Improve the Provision of Information for Adults with Primary Brain Tumors and Their Caregivers
  179. Exercise barriers self-efficacy: development and validation of a subcale for individuals with cancer-related lymphedema
  180. Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer
  181. Women’s Perceptions of Their Lifestyle and Quality of Life Several Years After a Diagnosis of Endometrial Cancer
  182. Evaluation of a skin self examination attitude scale using an item response theory model approach
  183. Prevalence, predictors, and correlates of supportive care needs among women 3–5 years after a diagnosis of endometrial cancer
  184. Changes in Outdoor Workersʼ Sun-Related Attitudes, Beliefs, and Behaviors
  185. Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial
  186. Primary Prevention of Skin Cancer
  187. Lesion Selection by Melanoma High-Risk Consumers During Skin Self-examination Using Mobile Teledermoscopy
  188. Quality of life of women with lower limb swelling or lymphedema 3–5years following endometrial cancer
  189. Clinical Skin Examination Outcomes After a Video-Based Behavioral Intervention
  190. Uptake of Skin Self-examination and Clinical Examination Behavior by Outdoor Workers
  191. Mobile Medical Applications for Melanoma Risk Assessment: False Assurance or Valuable Tool?
  192. Teledermatology: Its Use in the Detection and Management of Actinic Keratosis
  193. Interventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review
  194. Serum HE4 as a prognostic marker in endometrial cancer — A population based study
  195. Skin cancer detection by one click — are we any closer?
  196. Epidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer
  197. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer-A population-based data linkage study
  198. An Instrument to Measure Adherence to Weight Loss Programs: The Compliance Praxis Survey-Diet (COMPASS-Diet)
  199. Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia
  200. Advances in Skin Cancer Early Detection and Diagnosis
  201. The HealthyTexts study: A randomized controlled trial to improve skin cancer prevention behaviors among young people
  202. Determinants of Uptake of Whole-Body Skin Self-Examination in Older Men
  203. Nomogram to Predict the Probability of Relapse in Patients Diagnosed With Borderline Ovarian Tumors
  204. Enhanced Skin Self-examination: A Novel Approach to Skin Cancer Monitoring and Follow-up
  205. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
  206. Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE Trial
  207. Predicting positive and negative impacts of cancer among long-term endometrial cancer survivors
  208. Health professionals' perspectives on information provision for patients with brain tumours and their families
  209. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  210. Quality and Readability of Information Materials for People with Brain Tumours and Their Families
  211. How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia
  212. Characteristics of men aged 50 years or older who do not take up skin self-examination following an educational intervention
  213. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  214. The Children and Sunscreen Study
  215. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature
  216. Possible Genetic Predisposition to Lymphedema after Breast Cancer
  217. Development and piloting of a brain tumour-specific question prompt list
  218. Personalised electronic messages to improve sun protection in young adults
  219. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
  220. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study
  221. Lymphedema After Breast or Gynecological Cancer: Use and Effectiveness of Mainstream and Complementary Therapies
  222. Impact of a Video-Based Intervention to Improve the Prevalence of Skin Self-examination in Men 50 Years or Older
  223. Quality of life of women with lower-limb lymphedema following gynecological cancer
  224. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice
  225. Factors associated with recall of media reports about vitamin D and sun protection
  226. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma
  227. In Vitro Model of Vitamin D Synthesis by UV Radiation in an Australian Urban Environment
  228. Laparoscopy or laparotomy for early endometrial cancer? – Authors' reply
  229. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
  230. Patterns, correlates, and prognostic significance of quality of life following breast cancer
  231. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting
  232. Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study
  233. Knowledge about health benefits of vitamin D in Queensland Australia
  234. Seasonal Variation in Measured Solar Ultraviolet Radiation Exposure of Adults in Subtropical Australia
  235. The skin awareness study: Promoting thorough skin self-examination for skin cancer among men 50years or older
  236. Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study
  237. Gynecological cancer survivors and community support services: referral, awareness, utilization and satisfaction
  238. What determines the health‐related quality of life among regional and rural breast cancer survivors?
  239. Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer
  240. Recruiting older adults to health research studies: A systematic review
  241. Lymphedema Following Breast Cancer
  242. Vitamin D and sun protection: The impact of mixed public health messages in Australia
  243. Views of supervisors of colonoscopy training on quality issues for the national bowel cancer screening program in Australia
  244. Factors Associated With the Number of Lesions Excised for Each Skin Cancer
  245. The Queensland cancer risk study: general population norms for the Functional Assessment of Cancer Therapy–General (FACT‐G)
  246. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma
  247. Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care
  248. Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function
  249. Unmet supportive care needs and interest in services among patients with a brain tumour and their carers
  250. Gynecological cancer survivors’ health behaviors and their associations with quality of life
  251. Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia
  252. Elderly patients with stage III or IV ovarian cancer: should they receive standard care?
  253. Quality of life among patients with a brain tumor and their carers
  254. Medical cost-offsets from psychosocial care in breast cancer
  255. Sun protection and low levels of vitamin D: are people concerned?
  256. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions
  257. Lymphedema after gynecological cancer treatment
  258. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme
  259. Malnutrition among gynaecological cancer patients
  260. Reply
  261. What motivates men age ≥ 50 years to participate in a screening program for melanoma?
  262. Total laparoscopic versus open surgery for stage 1 endometrial cancer: The LACE randomized controlled trial
  263. Supportive care needs of people with brain tumours and their carers
  264. Do Centralised Skin Screening Clinics Increase Participation in Melanoma Screening (Australia)?
  265. Clinical outcomes from skin screening clinics within a community-based melanoma screening program
  266. Who attends skin cancer clinics within a randomized melanoma screening program?
  267. Voluntary whole-blood donors, and compensated platelet donors and plasma donors: Motivation to donate, altruism and aggression
  268. Increase in skin cancer screening during a community-based randomized intervention trial
  269. The functional assessment of cancer-vulvar: Reliability and validity
  270. Acceptability and feasibility of a community-based screening programme for melanoma in Australia
  271. Comparability of Skin Screening Histories Obtained by Telephone Interviews and Mailed Questionnaires: A Randomized Crossover Study
  272. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT
  273. Primary prevention of skin cancer: a review of sun protection in Australia and internationally
  274. Vulvar cancer patients' quality of life: a qualitative assessment
  275. Attitudes and intentions in relation to skin checks for early signs of skin cancer
  276. Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)
  277. Validity of Self-reported Skin Screening Histories
  278. Impaired Quality of Life in Patients Commencing Radiotherapy for Cancer
  279. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival
  280. Acute Side Effects during 3-D-Planned Conformal Radiotherapy of Prostate Cancer
  281. Impact of Videotaped Information on Frequency and Confidence of Breast Self-Examination
  282. Measurement of Quality of Life in Head and Neck Cancer Patients Utilizing the Quality of Life Radiation Therapy Questionnaire
  283. Primary fallopian tube carcinoma: the Queensland experience
  284. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma
  285. Quality of life changes during conformal radiation therapy for prostate carcinoma